Lian et al.
[Bis[2-(3,5-dimethyl-1-pyrazolyl)ethyl]amide]AlEt2 (5). The
same procedure was used as for 4, starting from 3 (50.0 mg, 0.130
mmol), giving complex 5 over 95% NMR purity. 1H NMR
(C6D6): δ 5.50 (s, 2H, pyrazole-H), 3.67 (t, 3J ) 6.1, 4H,
(s, 6H, pyrazole-CH3), 2.00 (s, 3H, p-CH3-Ph), 1.80 (s, 6H,
pyrazole-CH3), -0.52 (s, 6H, Al(CH3)2). 13C{1H} NMR (C6D6):
δ 153.22 (OCdCH2), 147.54 (pyrazole-CCH3), 138.73 (Ph), 138.38
(pyrazole-CCH3), 136.82 (Ph), 132.75 (Ph), 128.33 (Ph), 104.50
(pyrazole-CH), 95.54 (CdCH2), 49.14 (NCH2CH2-pyrazole), 47.90
(NCH2CH2-pyrazole), 20.78 (p-CH3-Ph), 20.05 (o-CH3-Ph), 13.60
(pyrazole-CH3), 10.57 (pyrazole-CH3), -9.89 (Al(CH3)2).
Reaction of 2 with 2,4,6-Trimethylacetophenone: Generation
of 8. Complex 2 (12.0 mg, 0.036 mmol) and 2,4,6-Me3C6H2COCH3
(5.8 mg, 0.036 mmol) were charged in a Teflon-valved NMR tube,
and C6D6 (ca. 0.5 mL) was vacuum transferred in. 1H NMR
spectroscopy was recorded, which revealed the formation of 8
(>95%) within 6 h at 60 °C. The NMR data of complex 8 were
the same as those reported above.
3
NCH2CH2-pyrazole), 3.24 (t, J ) 6.1, 4H, NCH2CH2-pyrazole),
2.34 (s, 6H, pyrazole-CH3), 1.69 (s, 6H, pyrazole-CH3), 1.38 (t, 3J
3
) 8.1, 6H, AlCH2CH3), 0.33 (q, J ) 8.1, 4H, AlCH2CH3). 13C-
{1H} NMR (C6D6): δ 147.55 (pyrazole-CCH3), 140.26 (pyrazole-
CCH3), 105.41 (pyrazole-CH), 51.63 (NCH2CH2-pyrazole), 50.23
(NCH2CH2-pyrazole), 13.14 (pyrazole-CH3), 10.68 (pyrazole-CH3),
10.16 (AlCH2CH3), 1.37 (AlCH2CH3). Anal. calcd. for C18H32AlN5
(345.46): C, 62.58; H, 9.34; N, 20.27; found: C, 61.85; H, 9.67;
N, 20.78.
Reaction of 2 with LiO(iPrO)CdCMe2: Generation of 6. In
the glovebox, complex 2 (21.6 mg, 0.065 mmol) and LiO(iPrO)Cd
CMe2 (8.8 mg, 0.065 mmol) were charged in a Teflon-valved NMR
[Bis[2-(3,5-dimethyl-1-pyrazolyl)ethyl]amine]ZnEt2 (9). To a
solution of ligand 1 (0.306 g, 1.17 mmol) in toluene (5 mL) was
slowly added ZnEt2 (1.01 g, 15 wt % solution in hexane, 1.23 mmol)
at room temperature. The reaction mixture was stirred for 2 h. After
evaporation of volatiles under vacuum, the residue was recrystal-
lized from a ca. 1:10 toluene/pentane solution at -34 °C to give
colorless crystals of 9 (0.406 g, 90%). A suitable crystal was
1
tube, and C6D6 (ca. 0.5 mL) was vacuum transferred in. H NMR
spectroscopy was recorded, which revealed the quantitative forma-
tion of 6, together with release of 1 equiv of (CH3)2CHCO2iPr.
The solution was dried in vacuo, and the white solid residue was
recrystallized from pentane at -34 °C to give colorless crystals of
6 (17 mg, 75%), of which some were suitable for X-ray diffraction
1
selected for X-ray diffraction analysis. H NMR (C6D6): δ 5.61
1
3
analysis. H NMR (C6D6): δ 5.53 (s, 2H, pyrazole-H), 3.72 (m,
(s, 2H, pyrazole-H), 3.52 (t, J ) 5.5, 4H, NCH2CH2-pyrazole),
2.68 (q, 3J ) 5.5, 4H, NCH2CH2-pyrazole), 2.29 (s, 6H, pyrazole-
CH3), 1.70 (s, 6H, pyrazole-CH3), 1.55 (t, 3J ) 8.1, 6H, Zn-
(CH2CH3)2), 0.42 (q, 3J ) 8.1, 4H, Zn(CH2CH3)2). 13C{1H} NMR
(C6D6): δ 147.64 (pyrazole-CCH3), 138.78 (pyrazole-CCH3),
104.89 (pyrazole-CH), 49.11 (NCH2CH2-pyrazole), 46.61 (NCH2CH2-
pyrazole), 13.99 (Zn(CH2CH3)2), 13.47 (pyrazole-CH3), 10.45
(pyrazole-CH3), 2.83 (Zn(CH2CH3)2). Anal. calcd. for C18H33N5-
Zn (384.88): C, 56.17; H, 8.64; N, 18.20; found: C, 55.83; H,
8.32; N, 18.65.
[Bis[2-(3,5-dimethyl-1-pyrazolyl)ethyl]amide]ZnEt (10). In the
glovebox, complex 9 (0.105 g, 0.273 mmol) was charged in a
Teflon-valved NMR tube, and C6D6 (ca. 0.5 mL) was vacuum
transferred in. The tube was sealed and kept at 60 °C for 2 days.
1H NMR spectroscopy was recorded, which revealed the quantita-
tive formation of 10, together with release of CH3CH3 (δ 1H (C6D6)
0.79 ppm). Cooling the solution gave large amounts of colorless
crystals of 10 (92 mg, 94%), of which some were suitable for X-ray
diffraction analysis. 1H NMR (C6D6): δ 5.58 (s, 2H, pyrazole-H),
2H, NCH2CH2-pyrazole, syn), 3.58 (m, 2H, NCH2CH2-pyrazole,
syn), 3.49 (m, 2H, NCH2CH2-pyrazole, anti), 2.53 (m, 2H, NCH2-
CH2-pyrazole, anti), 2.09 (s, 6H, pyrazole-CH3), 1.59 (s, 6H,
pyrazole-CH3), -0.39 (s, 9H, Al(CH3)3). 13C{1H} NMR (C6D6):
δ 147.56 (pyrazole-CCH3), 139.72 (pyrazole-CCH3), 104.63 (pyra-
zole-CH), 54.43 (NCH2CH2-pyrazole), 49.06 (NCH2CH2-pyrazole),
13.06 (pyrazole-CH3), 10.43 (pyrazole-CH3), -8.10 (Al(CH3)3).
NMR data for (CH3)2CHCO2iPr: 1H NMR (C6D6): δ 5.01 (sept,
3J ) 6.9, 1H, OCH(CH3)2), 2.36 (sept, 3J ) 6.3, 1H, (CH3)2CHCO),
1.05 (d, 3J ) 6.9, 6H, OCH(CH3)2), 1.02 (d, 3J ) 6.3, 6H, (CH3)2-
CHCO). 13C{1H} NMR (C6D6): δ 176.51 (COOiPr), 67.02 (OCH-
(CH3)2), 34.43 ((CH3)2CHCO), 21.49 (OCH(CH3)2), 18.87 ((CH3)2-
CHCO). Anal. calcd. for C17H31AlLiN5 (339.38): C, 60.16; H, 9.21;
N, 20.64; found: C, 60.32; H, 9.18; N, 20.75.
Reaction of 4 with LiO(iPrO)CdCMe2: Generation of 7.
Complex 4 (30.0 mg, 0.090 mmol) and LiO(iPrO)CdCMe2 (12.2
mg, 0.090 mmol) were charged in a Teflon-valved NMR tube, and
1
C6D6 (ca. 0.5 mL) was vacuum transferred in. H NMR spectros-
3
3
4.05 (t, J ) 6.0, 4H, NCH2CH2-pyrazole), 3.30 (t, J ) 6.0, 4H,
NCH2CH2-pyrazole), 2.25 (s, 6H, pyrazole-CH3), 1.75 (s, 6H,
copy was recorded, which revealed the quantitative formation of
1
3
7. H NMR (C6D6): δ 5.54 (s, 2H, pyrazole-H), 4.54 (sept, J )
6.2, 1H, OCH(CH3)2), 3.63 (m, 2H, NCH2CH2-pyrazole, syn), 3.55
(m, 2H, NCH2CH2-pyrazole, syn), 3.33 (m, 2H, NCH2CH2-pyrazole,
anti), 2.48 (m, 2H, NCH2CH2-pyrazole, anti), 2.18 (s, 6H, pyrazole-
CH3), 1.94 (s, 3H, (CH3)2CdC), 1.84 (s, 3H, (CH3)2CdC), 1.59
(s, 6H, pyrazole-CH3), 1.27 (d, 3J ) 6.2, 6H, OCH(CH3)2), -0.34
(s, 6H, Al(CH3)2). 13C{1H} NMR (C6D6): δ 150.59 ((CH3)2Cd
C), 147.60 (pyrazole-CCH3), 139.06 (pyrazole-CCH3), 104.85
(pyrazole-CH), 84.78 ((CH3)2CdC), 68.01 ((CH3)2CHO), 54.43
(NCH2CH2-pyrazole), 49.69 (NCH2CH2-pyrazole), 22.25 ((CH3)2-
CHO), 18.02 ((CH3)2CdC), 13.11 (pyrazole-CH3), 10.45 (pyrazole-
CH3), -8.90 (Al(CH3)2).
3
3
pyrazole-CH3), 1.54 (t, J ) 8.0, 3H, ZnCH2CH3), 0.55 (q, J )
8.0, 4H, ZnCH2CH3). 13C{1H} NMR (C6D6): δ 147.47 (pyrazole-
CCH3), 139.03 (pyrazole-CCH3), 104.87 (pyrazole-CH), 54.47
(NCH2CH2-pyrazole),47.91(NCH2CH2-pyrazole),14.35(ZnCH2CH3),
13.46 (pyrazole-CH3), 10.56 (pyrazole-CH3), 1.10 (ZnCH2CH3).
Anal. calcd. for C16H27N5Zn (354.81): C, 54.16; H, 7.67; N, 19.74;
found: C, 54.05; H, 7.48; N, 19.86.
[Bis[2-(3,5-dimethyl-1-pyrazolyl)ethyl]amide]ZnEt.ZnEt2 (11).
To a solution of 1 (128 mg, 0.49 mmol) in toluene (5 mL) was
slowly added ZnEt2 (1.33 mL of a 1.1 M solution in toluene, 1.46
mmol) at room temperature. The reaction mixture was stirred for
16 h at 120 °C under strictly anaerobic conditions. Volatiles were
removed under vacuum, and the solid residue was analyzed by 1H
NMR in C6D6, revealing the formation of 10 (ca. 80%) with other
multiple, complex resonances assigned to the diethylzinc adduct
(11; ca. 20%). The residue was recrystallized from toluene at -34
°C to give a few colorless crystals of 11, which proved suitable
for X-ray diffraction analysis.
Reaction of 4 with 2,4,6-Trimethylacetophenone: Generation
of 8. Complex 4 (11.5 mg, 0.036 mmol) and 2,4,6-Me3C6H2COCH3
(5.8 mg, 0.036 mmol) were charged in a Teflon-valved NMR tube,
and C6D6 (ca. 0.5 mL) was vacuum transferred in. 1H NMR
spectroscopy was recorded, which revealed the quantitative forma-
tion of 8 within 2 h. 1H NMR (C6D6): δ 6.68 (s, 2H, Ph), 5.67 (s,
2
2
2H, pyrazole-H), 4.79 (d, J ) 2.4, 1H, CdCHH), 4.03 (d, J )
2.4, 1H, CdCHH), 3.61 (t, 3J ) 6.0, 4H, NCH2CH2-pyrazole), 2.71
(q, 3J ) 6.0, 4H, NCH2CH2-pyrazole), 2.32 (s, 6H, o-CH3-Ph), 2.26
[Bis[2-(3,5-dimethyl-1-pyrazolyl)ethyl]amide]Zn2Et2(µ-
OEt) (12). (a) Synthesis of 12 from ZnEt2 and 1 under Aerobic
338 Inorganic Chemistry, Vol. 46, No. 1, 2007